Literature DB >> 21308535

Clinical trial report: is it safe to continue anticoagulation therapy in patients with infective endocarditis?

Donald P Levine1.   

Abstract

Entities:  

Year:  2010        PMID： 21308535     DOI： 10.1007/s11908-010-0109-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN： 1523-3847            Impact factor:   3.725


× No keyword cloud information.
  4 in total

1.  Reduction of bacterial titers by low-dose aspirin in experimental aortic valve endocarditis.

Authors:  D P Nicolau; C D Freeman; C H Nightingale; R Quintiliani; C J Coe; E G Maderazo; B W Cooper
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

2.  Impact of prior antiplatelet therapy on risk of embolism in infective endocarditis.

Authors:  Nandan S Anavekar; Imad M Tleyjeh; Nagesh S Anavekar; Zaur Mirzoyev; James M Steckelberg; Christopher Haddad; Masud H Khandaker; Walter R Wilson; Krishnaswamy Chandrasekaran; Larry M Baddour
Journal:  Clin Infect Dis       Date:  2007-03-14       Impact factor: 9.079

3.  A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis.

Authors:  Kwan-Leung Chan; Jean G Dumesnil; Bibiana Cujec; Anthony J Sanfilippo; John Jue; Michele A Turek; Trevor I Robinson; David Moher
Journal:  J Am Coll Cardiol       Date:  2003-09-03       Impact factor: 24.094

4.  Influence of aspirin on development and treatment of experimental Staphylococcus aureus endocarditis.

Authors:  D P Nicolau; M N Marangos; C H Nightingale; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.